CODX

0.2625

1.65% -0.0044

Dopo l'orario di chiusura: .28 0.0175 +6.67%

Co Diagnostics Inc (CODX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.2669

Aprire:

$0.27

Volume 24 ore:

577.92K

Relative Volume:

1.60

Capitalizzazione di mercato:

$9.83M

Reddito:

$7.11M

Utile/perdita netta:

$-41.28M

Rapporto P/E:

-0.1902

EPS:

-1.38

Flusso di cassa netto:

$-26.84M

1 W Prestazione:

+0.31%

1M Prestazione:

+5.42%

6M Prestazione:

-64.04%

1 anno Prestazione:

-79.33%

Intervallo 1D:

$0.2625

$0.2928

Intervallo di 1 settimana:

$0.25

$0.2928

Portata 52W:

$0.2275

$2.2299

Co Diagnostics Inc Stock (CODX) Company Profile

Nome

Co Diagnostics Inc

Settore

Healthcare (1174)

Industria

Medical Devices (149)

Telefono

(801) 278-9769

Indirizzo

4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY

Dipendente

132

Cinguettio

@Co_Diagnostics

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

CODX's Discussions on Twitter

Confronta CODX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CODX Co Diagnostics Inc	0.2625	9.83M	7.11M	-41.28M	-26.84M	-1.38
ABT Abbott Laboratories	134.38	233.36B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	106.53	147.06B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	393.55	145.64B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	86.02	112.76B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	78.21	44.46B	5.54B	4.18B	623.10M	7.00

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-08-12	Downgrade	Sidoti	Buy → Neutral
2021-12-29	Iniziato	Sidoti	Buy
2021-03-29	Downgrade	Maxim Group	Buy → Hold
2020-05-20	Aggiornamento	Maxim Group	Hold → Buy
2020-05-18	Reiterato	H.C. Wainwright	Buy
2020-03-09	Reiterato	H.C. Wainwright	Buy
2020-03-03	Downgrade	Maxim Group	Buy → Hold

Mostra tutto

Co Diagnostics Inc Borsa (CODX) Ultime notizie

Jun 07, 2025

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Deadline Approaching in Securities Class Action - ACCESS Newswire

Jun 07, 2025

CODX INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire

Jun 07, 2025

Jun 06, 2025

Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Up 19.5% in May - Defense World

Jun 06, 2025

Jun 04, 2025

Co-Diagnostics completes first FDA 510(k) application for Co-Dx PCR Pro - TipRanks

Jun 04, 2025

May 29, 2025

Co-Diagnostics Holds Annual Shareholders Meeting - TipRanks

May 29, 2025

May 21, 2025

Co-Diagnostics stock hits 52-week low at $0.27 amid market challenges - Investing.com Australia

May 21, 2025

May 16, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference | CODX Stock News - GuruFocus

May 14, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference - The Manila Times

May 14, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Capital Inaugural Global Conference on May 14, 2025 - Nasdaq

May 14, 2025

Co-Diagnostics Unveils Next-Gen PCR Testing Platform to Elite Institutional Investors - Stock Titan

May 14, 2025

May 10, 2025

Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025

May 09, 2025

Earnings call transcript: Co-Diagnostics Q1 2025 shows improved EPS and revenue decline - Investing.com Nigeria

May 09, 2025